RhumbLine Advisers’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-102,468
Closed -$963K 3059
2020
Q3
$963K Sell
102,468
-12,677
-11% -$119K ﹤0.01% 2008
2020
Q2
$881K Sell
115,145
-15,634
-12% -$120K ﹤0.01% 2095
2020
Q1
$808K Buy
130,779
+10,590
+9% +$65.4K ﹤0.01% 1977
2019
Q4
$1.46M Buy
120,189
+5,339
+5% +$65K ﹤0.01% 1915
2019
Q3
$1.33M Buy
114,850
+5,457
+5% +$63.1K ﹤0.01% 1912
2019
Q2
$1.09M Buy
109,393
+5,527
+5% +$55.2K ﹤0.01% 2027
2019
Q1
$1.34M Buy
103,866
+1,125
+1% +$14.5K ﹤0.01% 1899
2018
Q4
$1.56M Buy
102,741
+16,305
+19% +$248K ﹤0.01% 1799
2018
Q3
$1.73M Buy
86,436
+1,310
+2% +$26.2K ﹤0.01% 1737
2018
Q2
$1.66M Buy
85,126
+1,025
+1% +$20K ﹤0.01% 1770
2018
Q1
$1.7M Sell
84,101
-240
-0.3% -$4.84K ﹤0.01% 1698
2017
Q4
$1.12M Buy
84,341
+9,576
+13% +$127K ﹤0.01% 1893
2017
Q3
$1.38M Buy
74,765
+1,530
+2% +$28.2K ﹤0.01% 1821
2017
Q2
$1.35M Buy
73,235
+1,625
+2% +$29.9K ﹤0.01% 1791
2017
Q1
$1.62M Buy
71,610
+18,680
+35% +$421K ﹤0.01% 1671
2016
Q4
$1.84M Sell
52,930
-409
-0.8% -$14.2K ﹤0.01% 1499
2016
Q3
$1.31M Buy
53,339
+1,130
+2% +$27.7K ﹤0.01% 1672
2016
Q2
$1.25M Buy
52,209
+7,672
+17% +$184K ﹤0.01% 1650
2016
Q1
$1.04M Buy
44,537
+7,090
+19% +$166K ﹤0.01% 1764
2015
Q4
$1.13M Buy
37,447
+3,420
+10% +$103K ﹤0.01% 1731
2015
Q3
$1.35M Buy
34,027
+2,613
+8% +$104K ﹤0.01% 1597
2015
Q2
$2.17M Buy
31,414
+4,035
+15% +$279K 0.01% 1349
2015
Q1
$1.5M Buy
27,379
+3,310
+14% +$181K ﹤0.01% 1596
2014
Q4
$1.03M Sell
24,069
-2,150
-8% -$91.6K ﹤0.01% 1792
2014
Q3
$837K Sell
26,219
-170
-0.6% -$5.43K ﹤0.01% 1881
2014
Q2
$547K Buy
26,389
+2,749
+12% +$57K ﹤0.01% 2221
2014
Q1
$457K Sell
23,640
-2,080
-8% -$40.2K ﹤0.01% 2286
2013
Q4
$624K Hold
25,720
﹤0.01% 2119
2013
Q3
$552K Sell
25,720
-194
-0.7% -$4.16K ﹤0.01% 2149
2013
Q2
$577K Buy
+25,914
New +$577K ﹤0.01% 2151